SYNTA PHARMACEUTICALS CORP (SNTA) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 347 transactions totaling $99.3M, demonstrating a bullish sentiment with $81.8M in net insider flow. The most recent transaction on Jan 1, 2016 involved a transaction of 17,857 shares valued at $0.
No significant insider buying has been recorded for SNTA in the recent period.
No significant insider selling has been recorded for SNTA in the recent period.
Based on recent SEC filings, insider sentiment for SNTA is bullish with an Insider Alignment Score of 91/100 and a net flow of $81.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at SYNTA PHARMACEUTICALS CORP (SNTA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading SNTA stock, having executed 347 transactions in the past 90 days. The most active insider is Bruce Kovner (Executive), who has made 133 transactions totaling $134.1M.
Get notified when executives and directors at SNTA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 1, 2016 | D. Morenstein Scott | Executive | Award | 17,857 | $N/A | $0 | |
| Dec 14, 2015 | R. Gollust Keith | Executive | Sale | 300,000 | $0.32 | $96.0K | |
| Dec 11, 2015 | R. Gollust Keith | Executive | Sale | 300,000 | $0.37 | $111.0K | |
| Dec 9, 2015 | R. Gollust Keith | Executive | Sale | 145,892 | $0.38 | $55.4K | |
| Dec 8, 2015 | Kovner Bruce | Executive | Sale | 873,624 | $0.37 | $323.2K | |
| Dec 8, 2015 | Kovner Bruce | Executive | Sale | 496,015 | $0.37 | $183.5K | |
| Dec 8, 2015 | R. Gollust Keith | Executive | Sale | 300,000 | $0.38 | $114.0K | |
| Dec 7, 2015 | Kovner Bruce | Executive | Sale | 64 | $0.41 | $26 | |
| Dec 7, 2015 | Kovner Bruce | Executive | Sale | 36 | $0.41 | $15 | |
| Dec 7, 2015 | R. Gollust Keith | Executive | Sale | 300,000 | $0.39 | $117.0K | |
| Dec 4, 2015 | Kovner Bruce | Executive | Sale | 55,629 | $0.41 | $22.8K | |
| Dec 4, 2015 | Kovner Bruce | Executive | Sale | 97,978 | $0.41 | $40.2K | |
| Dec 3, 2015 | Kovner Bruce | Executive | Sale | 95,040 | $0.41 | $39.0K | |
| Dec 3, 2015 | Kovner Bruce | Executive | Sale | 167,394 | $0.41 | $68.6K | |
| Dec 2, 2015 | Kovner Bruce | Executive | Sale | 438,588 | $0.43 | $188.6K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 102 | $90.6M | 58.8% |
Award(A) | 106 | $53.6M | 34.8% |
Sale(S) | 59 | $8.7M | 5.7% |
Exercise(M) | 13 | $1.0M | 0.7% |
Payment(F) | 1 | $32.6K | 0.0% |
Other(J) | 13 | $0 | 0.0% |
Gift(G) | 48 | $0 | 0.0% |
Conversion(C) | 5 | $0 | 0.0% |
Insiders at SYNTA PHARMACEUTICALS CORP are accumulating shares at an accelerated pace. With 26 insiders making 347 transactions totaling $90.6M in purchases versus $8.7M in sales, the net buying activity of $81.8M signals strong executive confidence. Bruce Kovner (Executive) leads the buying activity with $134.1M in transactions across all time.